- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
MAXIND
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Max India Limited · Healthcare · Medical Care Facilities
Latest close
171.1 INR
-0.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 7.4% above the Trend Line and sits at 42.0% of its 52-week range. The latest completed week returned -0.7%, after a 4.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
42
out of 100
Latest Close
171.1 INR
7 Aug 2026
1W Return
-0.7%
latest completed week
4W Return
4.2%
short-term follow-through
12W Return
5.6%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.7%
Latest completed week; four-week move 4.2%.
Indicator stack
27/83
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 7.4% above the Trend Line and sits at 42.0% of its 52-week range. The latest completed week returned -0.7%, after a 4.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.20
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.2% over four weeks, 5.6% over 12 weeks, and -16.3% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.43Latest activity-pressure read.
Pressure change92.1%Four-week change in activity pressure.
Leadership-3.30Latest relative-leadership reading.
RS change54.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 76%
Model confidence 71%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth79/100Revenue and earnings growth. Underlying universe rank 22; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 5.0x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -14.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 72.3% Gross profit retained from each unit of revenue.
- Operating margin
- -66.5% Operating profit retained from revenue.
- Free-cash-flow margin
- -76.6% Free cash flow generated from revenue.
- Return on invested capital
- -19.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 31.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -17.4% Net share repurchases relative to market value.
- Shareholder yield
- -17.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.2%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+15.7%Week of 8 May.
Worst week-9.9%Week of 15 May.
Latest week-0.7%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks0
Modest losses6
Sharp losses7
Recent vol5.2%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank8 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape40/100
Trend, activity pressure, participation, and risk combine to a 40/100 tape read.
Indicator analysis41/100Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 1/12.
Activity pressure 0.24; No reversal markers Factors17/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 97; Small Cap Core rank 72 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Here's Why We're Watching Max India's (NSE:MAXIND) Cash Burn Situation Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 171.1 INR | -0.7% | 159.3 INR | 205.6 INR | 1.43 | -3.30 | 267.4K | On |
| 31 Jul 2026 | 172.2 INR | -5.4% | 159.5 INR | 205.6 INR | 1.38 | -2.28 | 1.1M | On |
| 24 Jul 2026 | 182.1 INR | 10.9% | 160.0 INR | 205.6 INR | 1.17 | 5.59 | 3.5M | On |
| 17 Jul 2026 | 164.2 INR | 0.0% | 160.1 INR | 205.5 INR | 0.77 | -7.31 | 328.5K | Off |
| 10 Jul 2026 | 164.2 INR | 2.9% | 160.9 INR | 205.4 INR | 0.74 | -7.20 | 261.5K | Off |
| 3 Jul 2026 | 159.6 INR | 0.3% | 161.8 INR | 205.4 INR | 0.62 | -10.19 | 74.2K | Off |
| 26 Jun 2026 | 159.0 INR | -5.3% | 163.0 INR | 205.2 INR | 0.59 | -9.91 | 0 | Off |
| 19 Jun 2026 | 168.0 INR | 6.0% | 164.4 INR | 205.0 INR | 0.76 | -4.87 | 48.9K | Off |
| 12 Jun 2026 | 158.4 INR | -1.3% | 165.2 INR | 204.7 INR | 0.64 | -8.88 | 21.2K | Off |
| 5 Jun 2026 | 160.5 INR | 0.2% | 166.8 INR | 204.4 INR | 0.66 | -6.93 | 43.4K | Off |
| 29 May 2026 | 160.2 INR | 3.6% | 168.6 INR | 204.0 INR | 0.88 | -7.95 | 982.4K | Off |
| 22 May 2026 | 154.6 INR | -4.6% | 170.4 INR | 203.7 INR | 0.69 | -11.92 | 156.3K | Off |
| 15 May 2026 | 162.0 INR | -9.9% | 172.3 INR | 203.3 INR | 0.79 | -7.63 | 149.9K | Off |
| 8 May 2026 | 179.7 INR | 15.7% | 173.9 INR | 202.8 INR | 0.78 | -0.02 | 280.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.